EARNINGS AND TRADING: Chapel Down hopes to make splash on AIM | Finance News shareprices.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from shareprices.com Daily Mail and Mail on Sunday newspapers.
MaxCyte Inc on Thursday said it expects revenue in the third quarter and for all of 2023 to fall from a year before, citing volatility in customer activity in the life science tools sector.
MaxCyte.
MaxCyte Inc on Thursday reported a widened operating loss in the first quarter of 2023 as revenue fell and costs were higher.
MaxCyte shares fell 18% to 310.00 pence each in London on Thursday. | May 11, 2023